Zeeberg B, Miörner H, Thelin I, Agren S, Schalén C
Department of Clinical Microbiology and Immunology, Lund University Hospital, Lund, Sweden.
Clin Microbiol Infect. 2005 Sep;11(9):761-4. doi: 10.1111/j.1469-0691.2005.01212.x.
Two amplification tests for the diagnosis of Chlamydia trachomatis infection, namely the ligase chain reaction (LCx) and the strand displacement assay (ProbeTec), were compared using samples from 1183 patients at sexually transmitted disease clinics. The overall prevalence of positive results was 8.0%, with agreement between the two assays of 98.8%. For endocervical, urethral and male urine samples, agreement was 99.3%, 99.4% and 97.7%, respectively. For ten discrepant samples, alternative amplification assays suggested that the LCx and ProbeTec assays gave erroneous results in six and four cases, respectively. Inhibition of amplification was observed with three (0.25%) urine specimens.
采用性传播疾病诊所1183例患者的样本,对两种用于诊断沙眼衣原体感染的扩增试验,即连接酶链反应(LCx)和链置换分析(ProbeTec)进行了比较。阳性结果的总体患病率为8.0%,两种检测方法的一致性为98.8%。对于宫颈内膜、尿道和男性尿液样本,一致性分别为99.3%、99.4%和97.7%。对于10例结果不一致的样本,其他扩增试验表明,LCx和ProbeTec检测分别在6例和4例中给出了错误结果。在3份(0.25%)尿液标本中观察到扩增抑制。